Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption

BACKGROUND: Vacc-4x, a therapeutic HIV vaccine candidate has previously induced a significant reduction in viral load (VL) set-point compared to placebo upon interruption of combination anti-retroviral therapy (ART) (2007/1 study). This study, (2012/1), explored the potential to maintain Vacc-4x eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Rockstroh, Jürgen K., Asmuth, David, Pantaleo, Giuseppe, Clotet, Bonaventura, Podzamczer, Daniel, van Lunzen, Jan, Arastéh, Keikawus, Mitsuyasu, Ronald, Peters, Barry, Silvia, Nozza, Jolliffe, Darren, Ökvist, Mats, Krogsgaard, Kim, Sommerfelt, Maja A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353572/
https://www.ncbi.nlm.nih.gov/pubmed/30699178
http://dx.doi.org/10.1371/journal.pone.0210965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353572/
https://www.ncbi.nlm.nih.gov/pubmed/30699178
http://dx.doi.org/10.1371/journal.pone.0210965

Ejemplares similares